A disease potential-driven graph attention model for comorbidity risk prediction of hypertension

Leming Zhou1, Hanshu Qin2, Yanmei Yang3

  • 1School of Computer Science and Technology, Chongqing University of Posts and Telecommunications, Chongqing, China.

Frontiers in Big Data
|April 20, 2026
PubMed

Insights

Hypertension patients face serious risks from comorbidities. A new Disease Potential-Driven Graph Attention (DP-GA) model improves comorbidity risk prediction, enhancing clinical interpretability and early detection.

Area of Science:

  • Medical Informatics
  • Computational Biology
  • Cardiovascular Disease Research

Background:

  • Hypertension significantly increases the risk of severe complications and comorbidities.
  • Current data-driven comorbidity prediction models lack clinical plausibility and interpretability.
  • Effective methods are needed to integrate patient features and identify individual differences for accurate risk prediction.

Purpose of the Study:

  • To develop an advanced model for predicting hypertension comorbidities.
  • To address limitations of existing data-driven prediction methods.
  • To enhance the interpretability and early detection of hypertension-related comorbidities.

Main Methods:

  • Proposed a novel Disease Potential-Driven Graph Attention (DP-GA) model.
  • Integrated patient disease features and structural information using a fusion mechanism.
  • Implemented a similarity-difference balance mechanism to differentiate patient relationships.
  • Designed a disease potential-driven attention mechanism for risk assessment and mask construction.

Main Results:

  • The DP-GA model demonstrated significant improvements in comorbidity risk prediction for hypertension patients.
  • Outperformed baseline and state-of-the-art methods across three comorbidity datasets.
  • Analysis of the comorbidity network enhanced prediction interpretability and early detection capabilities.

Conclusions:

  • The DP-GA model offers a robust and interpretable approach for hypertension comorbidity risk prediction.
  • This method effectively captures fused patient features and identifies critical relationships.
  • The findings support improved clinical decision-making and patient management for hypertension.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.3K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.9K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
817
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
95
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
977